Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura

Marshall A. Mazepa, Jay S. Raval, Stephan Moll, Alice Ma, Yara A. Park

Research output: Contribution to journalArticlepeer-review

34 Scopus citations
Original languageEnglish (US)
Pages (from-to)900-902
Number of pages3
JournalBritish journal of haematology
Issue number6
StatePublished - Mar 2014


  • Bortezomib
  • Thrombotic haemolytic anaemias
  • Thrombotic thrombocytopenic purpura

Cite this